JOURNALS

OncologySTAT identifies the latest, most important articles from the most respected sources in oncology.

  • Abstracts are available when the publisher grants permission

  • Summaries are created when the publisher does not grant permission for abstracts

  • And, in some cases, we are able to offer free access to full-text!

Journals indexed on OncologySTAT

Abstracts available >

Summaries available >

Journal Scans

The editors of OncologySTAT constantly scan the newest, most important journals, flagging the articles that are critical to oncologists. We highlight them here for your convenience.

Expert Commentary: In addition, we provide commentary from experts to put key articles into pespective.

Take-Home Message: A brief overview of the research article findings.

Read Journal Scans >

Review Articles

Browse our repository of thousands of articles to quickly and easily find reviews of greatest interest to you.

Editors' Pick: Our editors identify reviews of significant relevance

Read Review Articles>

Most Read Journal Scans

The most popular scans from February

NOAH Trial of Neoadjuvant Trastuzumab in HER2+ Breast Cancer

Lancet. 2010 Jan 30;375(9712):377-384, L Gianni, et al

Fracture Prevention Dubious With Bisphosphonates in Breast Cancer

Gynecol Oncol. 2010 Jan 12; Epub ahead of print, A Valachis, et al

Estimated Size of DCIS of the Breast Affects Success of BCS

Br J Cancer. 2010 Jan 5;102285-293, J Thomas, et al

Bortezomib Activity in Primary Systemic (Light-Chain) Amyloidosis

J Clin Oncol. 2010 Jan 19;Epub ahead of print, E Kastritis, et al

Carboplatin Plus Paclitaxel for Unresectable Thymic Carcinoma

Lung Cancer. 2010 Feb 1;67(2):194-197, S Igawa, et al

Most Read Review Articles

The most popular reviews from February

Electrolyte Disorders Related to EGFR-Targeting Drugs

Crit Rev Oncol Hematol. 2010 Mar 1;73(3):213-219, H Izzedine, et al

Antiangiogenesis Agents in Metastatic or Recurrent Cervical Cancer

Gynecol Oncol. 2010 Feb 1;116(2):181-186, BJ Monk, et al

Male Breast Cancer

Crit Rev Oncol Hematol. 2010 Feb 1;73(3):141-155, L Ottini, et al

Metabolic Syndrome in Cancer Survivors

Lancet Oncol. 2010 Feb 1;11(2):193-203, EC de Haas, et al

Immunomodulatory Agents in Oncology

Update Cancer Ther. 2009 May;3(4):170-181, T Zimmerman

Editors' Choice

Cetuximab and First-Line Taxane/Carboplatin in Advanced NSCLC

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Types Spotlight

  • Bladder
  • Bone
  • Breast
  • Breast (ER Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • HIV-Related Cancers
  • Bladder
  • Bone
  • Breast
  • Breast (ER Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • HIV-Related Cancers
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin (Melanoma)
  • Skin (Non-Melanoma)
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration